Wu Jinzi Jason - Net Worth and Insider Trading

Wu Jinzi Jason Net Worth

The estimated net worth of Wu Jinzi Jason is at least $5.5 Billion dollars as of 2025-07-10. Wu Jinzi Jason is the of Ascletis Pharma Inc and owns about 607,316,288 shares of Ascletis Pharma Inc (HKSE:01672) stock worth over $5.5 Billion. Details can be seen in Wu Jinzi Jason's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wu Jinzi Jason has not made any transactions after 2025-02-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Wu Jinzi Jason

To

Wu Jinzi Jason Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wu Jinzi Jason owns 1 companies in total, including Ascletis Pharma Inc (HKSE:01672) .

Click here to see the complete history of Wu Jinzi Jason’s form 4 insider trades.

Insider Ownership Summary of Wu Jinzi Jason

Ticker Company Transaction Date Type of Owner
HKSE:01672 Ascletis Pharma Inc 2025-02-18 2101 Beneficial owner

Wu Jinzi Jason Latest Holdings Summary

Wu Jinzi Jason currently owns a total of 1 stock. Wu Jinzi Jason owns 607,316,288 shares of Ascletis Pharma Inc (HKSE:01672) as of February 13, 2025, with a value of $5.5 Billion.

Latest Holdings of Wu Jinzi Jason

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01672 Ascletis Pharma Inc 2025-02-13 607,316,288 9.02 5,477,992,918

Holding Weightings of Wu Jinzi Jason


Wu Jinzi Jason Form 4 Trading Tracker

According to the SEC Form 4 filings, Wu Jinzi Jason has made a total of 8 transactions in Ascletis Pharma Inc (HKSE:01672) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Ascletis Pharma Inc is the sale of 0 shares on February 13, 2025, which brought Wu Jinzi Jason around $0.

Insider Trading History of Wu Jinzi Jason

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wu Jinzi Jason Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wu Jinzi Jason Ownership Network

Ownership Network List of Wu Jinzi Jason

No Data

Ownership Network Relation of Wu Jinzi Jason

Insider Network Chart


Wu Jinzi Jason Owned Company Details

What does Ascletis Pharma Inc do?

Who are the key executives at Ascletis Pharma Inc?

Wu Jinzi Jason is the 2101 Beneficial owner of Ascletis Pharma Inc. Other key executives at Ascletis Pharma Inc include 2201 Interest of corporation controlled by you Kang Hua Investment Company Limited , 2201 Interest of corporation controlled by you Yang Dan , and 2101 Beneficial owner Wu Judy Hejingdao .

Ascletis Pharma Inc (HKSE:01672) Insider Trades Summary

Over the past 18 months, Wu Jinzi Jason made 4 insider transaction in Ascletis Pharma Inc (HKSE:01672) with a net sale of 0. Other recent insider transactions involving Ascletis Pharma Inc (HKSE:01672) include a net sale of 0 shares made by Wu Judy Hejingdao , a net sale of 0 shares made by Jjw12 Limited , and a net sale of 7,228,958 shares made by Yang Dan .

In summary, during the past 3 months, insiders sold 0 shares of Ascletis Pharma Inc (HKSE:01672) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,457,916 shares of Ascletis Pharma Inc (HKSE:01672) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,457,916 shares.

Ascletis Pharma Inc (HKSE:01672)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ascletis Pharma Inc Insider Transactions

No Available Data

Wu Jinzi Jason Mailing Address

Above is the net worth, insider trading, and ownership report for Wu Jinzi Jason. Currently GuruFocus does not have mailing address information for Wu Jinzi Jason.